RAP1A and neonatal diabetes mellitus: RAP1 was undetectable in 36.4% of the NDM samples (12/33), and once verified in the NDM group, RAP1 immunostaining was very weak and predominantly restricted to the basal layer of the epithelium in 42.4% of the samples (14/33) and was classified as pattern 1 (as described in Material and Methods).